SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-11-025963
Filing Date
2011-03-16
Accepted
2011-03-16 16:30:19
Documents
3
Period of Report
2011-03-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c14252e8vk.htm 8-K 12242
2 EXHIBIT 99.1 c14252exv99w1.htm EX-99.1 8386
3 GRAPHIC c14252c1425201.gif GRAPHIC 16582
  Complete submission text file 0000950123-11-025963.txt   44842
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15070 | Film No.: 11692186
SIC: 2834 Pharmaceutical Preparations